Raybow USA in Brevard, NC, recently recognized Tim McElroy for completing 10 years of employment with the company. Parent company JiuZhou Pharmaceutical presented McElroy with a silver and gold commemorative coin in honor of his service.

Brevard staff members assembled to honor McElroy as Raybow USA President and General Manager Matt Lauer made the presentation.

McElroy commented, “The years have gone by quickly. I am glad I spent that time synthesizing a wide variety of compounds. I work with a great group of people who care about designing and developing smart, safe, and efficient synthesis, making compounds that meet our customers’ needs.”

Raybow USA President and General Manager Matt Lauer stated, “Our team in Brevard, North Carolina, is proud to have experienced, knowledgeable chemists like Tim on staff when customers seek our assistance with moving their innovative projects from the molecular stage to their specific markets.”

Contact Raybow USA for support with your integrated small-molecule CMC discovery, IND-enabling studies, and GMP manufacturing.

About Raybow USA

Founded in 1998 as PharmAgra Labs by Peter Newsome and Roger Frisbee, the Brevard, North Carolina, company became Raybow USA, a US branch of JiuZhou Pharma in 2019.

The facility is dedicated to cutting-edge Research & Development and Analytical services, offering preparation of clinical trial material, method validation, and small-scale specialty manufacturing for multiple markets. The FDA-inspected site boasts a cGMP laboratory and kilo lab.

About JiuZhou Pharma

Zhejiang JiuZhou Pharmaceutical Co., LTD. (stock code: 603456.SH), founded in 1998 and headquartered in Taizhou, Zhejiang, is a leading CDMO and generic drug manufacturer in China. The company has production and R&D bases in China, Germany, Japan, and the United States.

JiuZhou Pharma provides full-lifecycle contract development and manufacturing services to pharmaceutical companies worldwide. The one-stop CDMO service spans from preclinical research, process R&D for APIs, DPs, peptides, and drug conjugates, through all clinical phases to commercial production.

#syntheticchemistry #analyticalchemistry #pharmaceuticals #specialtychemicals #cdmo #pharmaceuticalresearchanddevelopment #methoddevelopment #gmp #smallmolecule

###